BIOS Capital Management, LP insider trades
BIOS Capital Management, LP has filed 3 Form 4s with the SEC that we hold, for In8Bio, INC. (INAB) (10% owner) and Actuate Therapeutics, INC. (ACTU) (Director, 10% owner). Across all of them we count 0 purchases worth $0 and 3 sales worth $200.0K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 17,361 shares of Actuate Therapeutics, INC. worth $138.9K, dated 2024-08-14. The first filing on our record is dated 2021-08-03 and the latest 2024-08-20.
In8Bio, INC. (INAB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Actuate Therapeutics, INC. (ACTU)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-14 | S, sale reported on Form 4 | 2,324 | $18.6K | 2024-08-20 |
| 2024-08-14 | S, sale reported on Form 4 | 5,314 | $42.5K | 2024-08-20 |
| 2024-08-14 | S, sale reported on Form 4 | 17,361 | $138.9K | 2024-08-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1813845) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms